Publication | Open Access

Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial

Era 223UrologyMedicineClinical TrialsPharmacotherapyCastration-resistant Prostate CancerBone MetastasesCancer TreatmentProstatic DiseaseOncologyOsteoporosis